Contribution: Industrial Research Assistance Program – Contributions to Firms
Pawsperity Biotechnologies Inc.
$182,000.00
Development of a microbiome diagnostic test for feline diabetes and other chronic conditions
FY 2020-21 · 2020-05-01
Summary
This project will involve the development and validation of an innovative molecular diagnostic for feline diabetes, as well as the expansion of this test to detect other small animal diseases beyond diabetes.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Vancouver|Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
753696913
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-05-01 | 2020-21 | $186,000.00 |
| 3 | 2020-05-01 | 2020-21 | $151,000.00 |
| 4 | 2020-05-01 | 2020-21 | $151,000.00 |
| 5 | 2020-05-01 | 2020-21 | $182,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 14 days. The total amended value is 31,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 14 jours. La valeur totale des modifications est de 31 000 dollars.
Agreement End Date
2023-03-31
Agreement Number
948927
Agreement Start Date
2020-05-01
Agreement Title
Development of a microbiome diagnostic test for feline diabetes and other chronic conditions
Agreement Title (French)
Mise au point d'un test de diagnostic du microbiome pour le diabète félin et d'autres maladies chroniques
Agreement Type
Contribution
Agreement Value
$182,000.00
Amendment Date
2023-02-02
Amendment Number
5
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will involve the development and validation of an innovative molecular diagnostic for feline diabetes, as well as the expansion of this test to detect other small animal diseases beyond diabetes.
Description (French)
Ce projet comprendra la mise au point et la validation d'un diagnostic moléculaire innovant pour le diabète félin, ainsi que l'extension de ce test pour détecter d'autres maladies de petits animaux au-delà du diabète.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
753696913
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Pawsperity Biotechnologies Inc.
Recipient Postal Code
V6J 2H8
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2020-2021-Q1-948927
